Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (151-160 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|July 7, 2023
GRAPPA 2021 Pilot Grant Award ReportsFazira R Kasiem, Daisuke Yamada, Josefina Marin, et al.
Rheumatic Diseases Clinics of North America|April 17, 2026
Molecular Biomarkers for Predicting Treatment Response in Psoriatic ArthritisAndre Lucas Ribeiro, Anne Barton, Jochen M Schwenk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Higher Coronary Plaque Burden in Psoriatic Arthritis Is Independent of Metabolic Syndrome and Associated With Underlying Disease SeverityAgnes Szentpetery, Gerard M Healy, Darragh Brady, et al.
The Journal of Rheumatology|May 3, 2016
GRAPPA 2015 Research and Education Project ReportsPhilip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Rheumatology (Oxford, England)|April 14, 2017
A new era for collaboration?Jonathan C Packham, Sonya Abraham, Bruce Kirkham, et al.
Rheumatology and Therapy|May 23, 2022
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 TrialsPhilip Mease, Arthur Kavanaugh, Dafna Gladman, et al.
The Journal of Rheumatology|March 5, 2013
Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritisAgnes Szentpetery, Malachi J McKenna, Barbara F Murray, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Nature Reviews. Disease Primers|August 13, 2021
Psoriatic arthritisOliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Pageof 29

Showing results (151-160 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|July 7, 2023
GRAPPA 2021 Pilot Grant Award ReportsFazira R Kasiem, Daisuke Yamada, Josefina Marin, et al.
Rheumatic Diseases Clinics of North America|April 17, 2026
Molecular Biomarkers for Predicting Treatment Response in Psoriatic ArthritisAndre Lucas Ribeiro, Anne Barton, Jochen M Schwenk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Higher Coronary Plaque Burden in Psoriatic Arthritis Is Independent of Metabolic Syndrome and Associated With Underlying Disease SeverityAgnes Szentpetery, Gerard M Healy, Darragh Brady, et al.
The Journal of Rheumatology|May 3, 2016
GRAPPA 2015 Research and Education Project ReportsPhilip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Rheumatology (Oxford, England)|April 14, 2017
A new era for collaboration?Jonathan C Packham, Sonya Abraham, Bruce Kirkham, et al.
Rheumatology and Therapy|May 23, 2022
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 TrialsPhilip Mease, Arthur Kavanaugh, Dafna Gladman, et al.
The Journal of Rheumatology|March 5, 2013
Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritisAgnes Szentpetery, Malachi J McKenna, Barbara F Murray, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Nature Reviews. Disease Primers|August 13, 2021
Psoriatic arthritisOliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Pageof 29